Correlation Between Biomea Fusion and Ironwood Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Biomea Fusion and Ironwood Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomea Fusion and Ironwood Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomea Fusion and Ironwood Pharmaceuticals, you can compare the effects of market volatilities on Biomea Fusion and Ironwood Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomea Fusion with a short position of Ironwood Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomea Fusion and Ironwood Pharmaceuticals.
Diversification Opportunities for Biomea Fusion and Ironwood Pharmaceuticals
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between Biomea and Ironwood is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Biomea Fusion and Ironwood Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ironwood Pharmaceuticals and Biomea Fusion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomea Fusion are associated (or correlated) with Ironwood Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ironwood Pharmaceuticals has no effect on the direction of Biomea Fusion i.e., Biomea Fusion and Ironwood Pharmaceuticals go up and down completely randomly.
Pair Corralation between Biomea Fusion and Ironwood Pharmaceuticals
Given the investment horizon of 90 days Biomea Fusion is expected to under-perform the Ironwood Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Biomea Fusion is 1.1 times less risky than Ironwood Pharmaceuticals. The stock trades about -0.52 of its potential returns per unit of risk. The Ironwood Pharmaceuticals is currently generating about -0.16 of returns per unit of risk over similar time horizon. If you would invest 415.00 in Ironwood Pharmaceuticals on August 28, 2024 and sell it today you would lose (80.00) from holding Ironwood Pharmaceuticals or give up 19.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biomea Fusion vs. Ironwood Pharmaceuticals
Performance |
| Timeline |
| Biomea Fusion |
| Ironwood Pharmaceuticals |
Biomea Fusion and Ironwood Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biomea Fusion and Ironwood Pharmaceuticals
The main advantage of trading using opposite Biomea Fusion and Ironwood Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomea Fusion position performs unexpectedly, Ironwood Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ironwood Pharmaceuticals will offset losses from the drop in Ironwood Pharmaceuticals' long position.| Biomea Fusion vs. Edgewise Therapeutics | Biomea Fusion vs. Werewolf Therapeutics | Biomea Fusion vs. Cullinan Oncology LLC | Biomea Fusion vs. Design Therapeutics |
| Ironwood Pharmaceuticals vs. Neurocrine Biosciences | Ironwood Pharmaceuticals vs. Amphastar P | Ironwood Pharmaceuticals vs. Collegium Pharmaceutical | Ironwood Pharmaceuticals vs. ANI Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |